Glatiramer Acetate (Professional Patient Advice) | 合法藥品大搜索
Home[1]
Glatiramer[2]
Monograph
Brand names: Copaxone[3], Glatopa [Web])Drug class: Amino Acid Polymers
IntroductionSynthetic polypeptide mixture containing 4 naturally occurring amino acids with immunomodulatory and disease-modifying activity in multiple sclerosis.
Uses for Glatiramer Acetate Multiple Sclerosis (MS)Treatment of adults with relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting MS (RRMS), and active secondary progressive MS.
Glatiramer acetate is one of several disease-modifying therapies used in the management of relapsing forms of MS. Although not curative, these therapies have all been shown to modify several measures of disease activity, including relapse rates, new or enhancing MRI lesions, and disability progression.
The A...
Glatiramer Acetate (Professional Patient Advice) | 合法藥品大搜索
Copaxone (Glatiramer Acetate) Side effects | 合法藥品大搜索
Copaxone (Glatiramer Acetate): Uses | 合法藥品大搜索
Glatiramer Injection | 合法藥品大搜索
Injecting Viatris' Glatiramer Acetate Injection with ... | 合法藥品大搜索
IMPORTANT SAFETY INFORMATION | 合法藥品大搜索
Viatris Advocate Co | 合法藥品大搜索
Glatiramer Acetate | 合法藥品大搜索
Patient Information Leaflet Glatiramer Acetate Injection (gla ... | 合法藥品大搜索
GLATIRAMER ACETATE | 合法藥品大搜索
【貝他費隆 注射劑】降低反覆發作型多發性硬化症的發作頻率及嚴重度。降低續發型多發性硬化症(secondary progressive multiple sclerosis)復發的頻率及嚴重度。發生單一臨床症狀(Clinically Isolated Syndrome)疑似多發性硬化症的病患，可延緩其惡化成多發性硬化症。
藥品名稱:貝他費隆 注射劑許可證字號:衛署菌疫輸字第000601號許可證種類:菌 疫適應症:降低反覆發作型多發性硬化症的發作頻...
【柯珮鬆注射液20毫克】Copaxone用於治療首次出現臨床症狀且有MRI為佐證之多發性硬化症病人。復發型多發性硬化症Copaxone，用於減少復發型多發性硬化病人的復發頻率。
藥品名稱:柯珮鬆注射液20毫克許可證字號:衛部罕藥輸字第000033號許可證種類:製 劑適應症:Copaxone用於治療首次出現臨床症狀...
【柯珮鬆注射液40毫克】用於復發型多發性硬化症，以減少復發型多發性硬化症病人的復發頻率。
藥品名稱:柯珮鬆注射液40毫克許可證字號:衛部罕藥輸字第000035號許可證種類:製 劑適應症:用於復發型多發性硬化症，以減少復...